COVID-19 Updates
IWK & COVID-19: Latest Updates
Hotline: 1-902-233-3495



Emergency: 911
Telecare: 811
Poison: 1-800-565-8161
5850/5980 University Ave., Halifax, NS B3K 6R8

Children with BPD/CLD : Palivizumab (Synagis®)

updated: November 2019

Seasonal administration of palivizumab should be considered for children <24 months of age with bronchopulmonary dysplasia (BPD) / chronic lung disease (CLD) and who have required oxygen within 6 months preceding the RSV season(i.e. June 1st - November 2019), or other pulmonary disorders requiring oxygen therapy (e.g. hypoplastic lung).